DFAS
Dimensional U.S. Small Cap ETF
DFAS actively invests in small-cap US companies, selected using multiple factors and weighted by market capitalization.
US
EQUITY
Active
MANAGEMENT STYLE
$ 17.0 B
ASSETS UNDER MGMT
26 bp
EXPENSES
Fund Basics
| Inception date | Jun 14, 2021 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| SAPIENS INTERNATIONAL CORP | 7.8 % |
| AMPLITECH GROUP INC | 3.1 % |
| CRANE HOLDINGS, CO. | 0.4 % |
| REGAL BELOIT CORP | 0.4 % |
| HF SINCLAIR CORPORATION | 0.3 % |
| JAZZ PHARMACEUTICALS PLC | 0.3 % |
| NANOMETRICS INC | 0.3 % |
| INTEGRATED ELECTRICAL SERVIC | 0.2 % |
| ELANCO ANIMAL HEALTH, INC. | 0.2 % |
| WESCO INTERNATIONAL INC | 0.2 % |
Constituent Breakdown
| Number of holdings | 2060 |
| Herfindahl-Hirschman Index | 83 |
| Wgt avg mkt cap (mns) | $67,166 |
| Large cap (>$10bn) | 27.9% |
| Mid cap ($2-10bn) | 57.2% |
| Small cap (<$2bn) | 11.9% |
| Developed mkts. | 97.0% |
| Emerging mkts. | 0.1% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 86.2 % |
 |
ISRAEL | 7.8 % |
 |
BERMUDA | 1.0 % |
 |
IRELAND | 0.7 % |
Historical Performance
Standardized Performance (as of 07/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 16.3% | 25.5% | 11.4% | 12.0% | 7.0% | -- | -- | 6.4% |
| Dividend Yield | 0.6% | 1.4% | 1.2% | 1.2% | 1.7% | -- | -- | 1.7% |
| Total Returns | 16.9% | 26.9% | 12.5% | 13.2% | 8.7% | -- | -- | 8.1% | Ann. Volatility | 16.4% | 16.7% | 20.2% | 19.4% | 20.7% | -- | -- | 20.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.00 | 59% |
| MSCI EAFE | 0.76 | 51% |
| MSCI Emg Mkts | 0.42 | 37% |
Liquidity Measures
| Avg. volume (000) | 511 |
| ADV traded (mns) | $42 |
| Turnover | 0.3% |
| Avg. Bid/Ask (% of price) | 0.02% |
Technical Indicators
| 30d moving avg. (EMA) | $80.62 |
| Relative strength (RSI) | 55 |
| MACD/Signal | 0.26/0.36 |
| Bollinger Bands (Upper/Lower) | $81.82/$80.18 |
| Short interest (% of AUM) | 0.2% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. DFAS |
Expenses vs. DFAS |
ALTAR Score™ vs. DFAS |
|---|---|---|---|---|
| ISCB | iShares Morningstar Small-Cap ETF | 64.0% | -22 bp | -0.2% |
| SMMD | iShares Russell 2500 ETF | 60.2% | -11 bp | +0.1% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 53.1% | -9 bp | -0.6% |
| VTWO | Vanguard Russell 2000 ETF | 52.7% | -19 bp | -2.8% |
| SCHA | Schwab U.S. Small-Cap ETF | 52.1% | -22 bp | -1.1% |
| VXF | Vanguard Extended Market ETF | 51.6% | -21 bp | -1.6% |
| ISCV | iShares Morningstar Small Cap Value ETF | 51.1% | -20 bp | +1.9% |
| VB | Vanguard Small-Cap ETF | 49.2% | -21 bp | -0.3% |
| VBR | Vanguard Small Cap Value ETF | 46.6% | -19 bp | +2.1% |
| EZM | WisdomTree U.S. MidCap Fund | 46.3% | +12 bp | +2.7% |
Risk and Returns: DFAS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 8/7/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.8%
ALTAR SCORE™
62nd
PERCENTILE
OVERWEIGHT
ETFRC RATING
There are 1,402 funds in the US Equity category with an average
ALTAR Score™ of 5.2% and a standard deviation
of 2.0%. DFAS's ALTAR Score™ is approximately 0.3 standard
deviations above the category average. This places DFAS in the 62nd percentile
among funds in the category.
Sell-Side Consensus
$89.97
PRICE TARGET
+8.8%
UPSIDE